Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The multiple sclerosis market.

× No keyword cloud information.

4 in total

1. Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.

Authors: Daniel Wynn; Michael Kaufman; Xavier Montalban; Timothy Vollmer; Jack Simon; Jacob Elkins; Gilmore O'Neill; Lauri Neyer; James Sheridan; Chungchi Wang; Alice Fong; John W Rose
Journal: Lancet Neurol Date: 2010-02-15 Impact factor: 44.182

Review 2. Interferon beta in the treatment of multiple sclerosis: mechanisms of action.

Authors: V W Yong; S Chabot; O Stuve; G Williams
Journal: Neurology Date: 1998-09 Impact factor: 9.910

3. Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator.

Authors: Mike Boggild; Jackie Palace; Pelham Barton; Yoav Ben-Shlomo; Thomas Bregenzer; Charles Dobson; Richard Gray
Journal: BMJ Date: 2009-12-02

4. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

Authors: Alasdair J Coles; D Alastair S Compston; Krzysztof W Selmaj; Stephen L Lake; Susan Moran; David H Margolin; Kim Norris; P K Tandon
Journal: N Engl J Med Date: 2008-10-23 Impact factor: 91.245

4 in total